What are the recommended medications and dosing for acute group A streptococcal infection?

Medications for Group A Streptococcal Infection

Penicillin or amoxicillin for 10 days is the first-line treatment for Group A streptococcal pharyngitis, with specific dosing based on age and weight. 1

First-Line Treatment (No Penicillin Allergy)

Oral therapy (preferred):

• Penicillin V:

  • Children: 250 mg twice or three times daily for 10 days
  • Adolescents/adults: 250 mg four times daily OR 500 mg twice daily for 10 days
  • Strong recommendation, high-quality evidence 1

• Amoxicillin (equally effective, better palatability):

  • 50 mg/kg once daily (maximum 1,000 mg) for 10 days, OR
  • 25 mg/kg twice daily (maximum 500 mg per dose) for 10 days
  • Strong recommendation, high-quality evidence 1

Intramuscular therapy (for compliance concerns):

• Benzathine penicillin G:
  • <60 lbs (27 kg): 600,000 units as single dose
  • ≥60 lbs: 1,200,000 units as single dose
  • Strong recommendation, high-quality evidence 1

Penicillin-Allergic Patients

For non-immediate hypersensitivity (Type IV reactions):

• Cephalexin: 20 mg/kg per dose twice daily (maximum 500 mg per dose) for 10 days 1
• Cefadroxil: 30 mg/kg once daily (maximum 1 g) for 10 days 1
• Both carry strong recommendations with high-quality evidence

For immediate hypersensitivity (anaphylaxis) or when avoiding all beta-lactams:

• Clindamycin: 7 mg/kg per dose three times daily (maximum 300 mg per dose) for 10 days

  • Strong recommendation, moderate-quality evidence 1

• Azithromycin: 12 mg/kg once daily (maximum 500 mg) for 5 days

  • Strong recommendation, moderate-quality evidence 1
  • Critical caveat: Geographic resistance varies significantly; local resistance patterns should guide use

• Clarithromycin: 7.5 mg/kg per dose twice daily (maximum 250 mg per dose) for 10 days

  • Strong recommendation, moderate-quality evidence 1

Key Clinical Considerations

Why penicillin remains first-line: Penicillin maintains its position as the drug of choice due to its narrow antimicrobial spectrum, proven efficacy, safety profile, and low cost 2. No Group A streptococcal resistance to penicillin has been documented, making it reliably effective 2. The narrow spectrum minimizes disruption to normal flora and reduces selection pressure for resistant organisms.

Duration matters: The 10-day duration is critical for maximal pharyngeal eradication of Group A streptococci 2. While some newer agents (azithromycin, certain cephalosporins) have been studied in shorter courses, the IDSA guidelines maintain that 10 days remains the standard for most antibiotics to prevent complications including acute rheumatic fever 1.

Macrolide resistance warning: Resistance of Group A streptococcus to macrolides (azithromycin, clarithromycin) varies geographically and temporally 1. In some regions, resistance exceeds 10-15%, making these less reliable choices. When prescribing macrolides, consider local resistance patterns and reserve for true penicillin allergy.

Cephalosporin considerations: First-generation cephalosporins should be avoided in patients with immediate (IgE-mediated) hypersensitivity to penicillin due to cross-reactivity risk 1. However, they are appropriate for delayed-type (Type IV) reactions. Some evidence suggests cephalosporins may have superior eradication rates compared to penicillin, but this does not justify routine use given penicillin's advantages 3.

Special Populations

Chronic carriers (recurrent positive cultures with viral symptoms): Treatment differs substantially for chronic carriers experiencing repeated viral infections. Options include 1:

• Clindamycin: 20-30 mg/kg/day in three doses (maximum 300 mg per dose) for 10 days
• Penicillin V + Rifampin: Penicillin V 50 mg/kg/day in four doses for 10 days PLUS rifampin 20 mg/kg/day for the last 4 days (maximum 600 mg/day)
• Amoxicillin/clavulanate: 40 mg amoxicillin/kg/day in three doses (maximum 2,000 mg/day) for 10 days

Invasive Group A streptococcal infections: For severe infections (necrotizing fasciitis, streptococcal toxic shock syndrome), parenteral therapy is required 4:

• Preferred: IV penicillin (100,000-250,000 U/kg/day every 4-6 hours) OR ampicillin (200 mg/kg/day every 6 hours)
• Add clindamycin (40 mg/kg/day every 6-8 hours) for toxin suppression in severe cases 5
• Linezolid is an alternative when clindamycin resistance is confirmed 5

Common Pitfalls to Avoid

1. Do not treat viral pharyngitis: Testing is not recommended when clinical features strongly suggest viral etiology (cough, rhinorrhea, hoarseness, oral ulcers) 6

2. Do not routinely test children <3 years: Acute rheumatic fever is rare in this age group unless specific risk factors exist 6

3. Do not perform post-treatment cultures routinely: Follow-up testing is unnecessary in most cases 6

4. Do not treat asymptomatic household contacts: Routine testing or empiric treatment of contacts is not recommended 6

5. Avoid aspirin in children: Use acetaminophen or NSAIDs for symptom control instead 1, 6

6. Do not use corticosteroids: Adjunctive corticosteroids are not recommended for Group A streptococcal pharyngitis 1, 6